The Antidotes market size is expected to reach $4.03 billion in 2030 at a CAGR of 10.9%, driven by increased poisoning incidents and expansion of emergency care infrastructure.
Read More
The Antidiarrheals market size is expected to reach $4.6 billion in 2030 at a CAGR of 2.9%, driven by rising gastrointestinal disorders and increasing self-medication trends.
Read More
The Antidepressants market size is expected to reach $20.54 billion in 2030 at a CAGR of 2.8%, driven by digital mental health adoption and advances in precision psychiatry.
Read More
The Anti-D Immunoglobulin market size is expected to reach $3.55 billion in 2030 at a CAGR of 6.5%, driven by antenatal screening programs and plasma fractionation technology expansion.
Read More
The Anticonvulsants market size is expected to reach $23.4 billion in 2030 at a CAGR of 4.1%, driven by precision medicine adoption and growth in geriatric epilepsy care.
Read More
The Anticoccidial Drugs market size is expected to reach $1.84 billion in 2030 at a CAGR of 6.2%, driven by intensive poultry farming and expansion of veterinary healthcare services.
Read More
The Anticoagulants market size is expected to reach $97.07 billion in 2030 at a CAGR of 12.6%, driven by growing atrial fibrillation prevalence and oral anticoagulant adoption.
Read More
The Anticoagulant Reversal Drugs market size is expected to reach $2.65 billion in 2030 at a CAGR of 9.8%, driven by increased DOAC usage and demand for rapid emergency reversal therapies.
Read More
The Anticholinergic Drugs market size is expected to reach $8.87 billion in 2030 at a CAGR of 7.0%, driven by formulation innovation and rising overactive bladder treatment demand.
Read More
The Anti-CD20 Monoclonal Antibodies market size is expected to reach $12.94 billion in 2030 at a CAGR of 7.5%, driven by biosimilar development and expanded autoimmune disease treatment use.
Read More